How many shares of XENE does GEODE CAPITAL MANAGEMENT, LLC own?

As of 2026-Q2, GEODE CAPITAL MANAGEMENT, LLC holds 1.4M shares of XENE (XENON PHARMACEUTICALS INC).

What is GEODE CAPITAL MANAGEMENT, LLC's XENE position worth?

As of 2026-Q2, GEODE CAPITAL MANAGEMENT, LLC's XENE position is worth $82.7M.

Is GEODE CAPITAL MANAGEMENT, LLC buying or selling XENE?

In 2026-Q2, GEODE CAPITAL MANAGEMENT, LLC increased their XENE position (+25.4% change in shares).

When did GEODE CAPITAL MANAGEMENT, LLC first buy XENE?

Based on available 13F filings, GEODE CAPITAL MANAGEMENT, LLC first reported a position in XENE in 2018-Q4. They have held the position across 31 quarters.

Back to

GEODE CAPITAL MANAGEMENT, LLC

XENE
31 quarters

Position history for GEODE CAPITAL MANAGEMENT, LLC's holdings in XENON PHARMACEUTICALS INC

Current Value

$82.7M

Current Shares

1.4M

Total Value Change

+$82.5M

Total Shares Change

+1.3M

Quarter-by-Quarter History

Quarter	Action	Shares	Change	Value	Weight	Price	Conviction
2026-Q2 Latest	Increased	1.4M	+25.4%	$82.7M	0.0%	$60.36	37
2026-Q1	Increased	1.1M	+14.7%	$63.5M	0.0%	$43.79	34
2025-Q4	Decreased	952,679	-2.5%	$42.7M	0.0%	$44.12	0
2025-Q3	Increased	977,435	+0.7%	$39.2M	0.0%	$39.06	29
2025-Q2	Increased	970,343	+1294.2%	$30.4M	0.0%	$32.40	46
2025-Q1	Increased	69,597	+0.1%	$2.3M	0.0%	$34.26	26
2024-Q4	Increased	69,529	+1.1%	$2.7M	0.0%	$38.53	26
2024-Q3	Decreased	68,809	-0.2%	$2.7M	0.0%	$38.65	0
2024-Q2	Increased	68,929	+7.3%	$2.7M	0.0%	$38.99	28
2024-Q1	Increased	64,229	+3.5%	$2.8M	0.0%	$43.05	27
2023-Q4	Increased	62,073	+10.9%	$2.9M	0.0%	$46.06	29
2023-Q3	Increased	55,945	+0.1%	$1.9M	0.0%	$34.16	26
2023-Q2	Increased	55,915	+0.3%	$2.2M	0.0%	$38.43	26
2023-Q1	Increased	55,725	+0.8%	$2M	0.0%	$35.61	26
2022-Q4	Decreased	55,285	-10.6%	$2.2M	0.0%	$39.43	0
2022-Q3	Increased	61,823	+35.8%	$2.2M	0.0%	$35.89	34
2022-Q2	Increased	45,516	+61.4%	$1.4M	0.0%	$30.90	37
2022-Q1	Unchanged	28,198	0.0%	$862,000	0.0%	$30.12	0
2021-Q4	Increased	28,198	+30.2%	$880,000	0.0%	$31.99	31
2021-Q3	Unchanged	21,650	0.0%	$330,000	0.0%	$14.86	0
2021-Q2	Increased	21,650	+12.5%	$403,000	0.0%	$18.05	27
2021-Q1	Unchanged	19,242	0.0%	$344,000	0.0%	$17.49	0
2020-Q4	Unchanged	19,242	0.0%	$295,000	0.0%	$16.04	0
2020-Q3	Unchanged	19,242	0.0%	$213,000	0.0%	$10.83	0
2020-Q2	Unchanged	19,242	0.0%	$241,000	0.0%	$12.01	0
2020-Q1	Decreased	19,242	-50.0%	$218,000	0.0%	$10.96	0
2019-Q4	Increased	38,484	+100.0%	$504,000	0.0%	$13.20	39
2019-Q3	Unchanged	19,242	0.0%	$173,000	0.0%	$8.77	0
2019-Q2	Increased	19,242	+36.6%	$189,000	0.0%	$9.86	20
2019-Q1	Decreased	14,084	-50.0%	$143,000	0.0%	$10.16	0
2018-Q4	New	28,168	-	$176,000	0.0%	$5.92	35

Other major holders of XENE: FMR LLC, BlackRock, Inc.

XENE31 quarters

XENE
31 quarters